No insider purchase over the last 90 days. The latest, by Yang Steve Qing, was filed 17 Jun 2026.
WuXi AppTec Co., Ltd. - H Shares, classified in the Health Care sector, is a listed company based in Shanghai, People's Republic of China, founded in 2000. Its insiders report their share dealings to HKEX. 5 insiders have disclosed 21 filings since 23 October 2025.
Purchases and sales both appear in the filings: 5 purchases (5 insiders) and 11 sales (5 insiders, €29.7M). The amount is not disclosed for 5 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €10.4M, sold by Li Ge and made public on 17 August 2026 (0.015% of market cap). Among those who bought: 5 senior executives.
The last insider purchase was made public on 17 June 2026, 131 days ago. Filings reach the HKEX feed a median of 6 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
With 21 filings in twelve months, the company is more active than the median of 4 filings across the 1,315 companies we follow on the same exchange. Over the whole record (from 2026), the tally stands at 5 purchases and 11 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Analysts rate WuXi AppTec Co., Ltd. - H Shares Strong Buy (bullish), based on 21 analysts. Average price target: HK$225.31.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
21 of 21 declarations
WuXi AppTec Co., Ltd. - H Shares is a research and development services company in the biopharmaceutical sector. It provides integrated solutions for drug discovery, development, and manufacturing.
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Shanghai, People's Republic of China · Founded: 2000 · Wikipedia article
Source: Wikidata (CC0).